Gerald Schmid‐Bindert

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort

Oliver Gautschi, Julie Milia, Bastien Cabarrou et al. · Journal of Thoracic Oncology · 2015 · 186 citations · Full text

Medicine, Pathology, European Euraf Cohort +8

High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules

Chunyan Wu, Chao Zhao, Yang Yang et al. · Journal of Thoracic Oncology · 2015 · 142 citations

Somatic Variant, Driver Mutations, Advanced Lung Disease +8

Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?

Gerald Schmid‐Bindert, Thomas Henzler, T. Q. Chu et al. · European Radiology · 2011 · 122 citations

Positron Emission Tomography, Engineering, Oncologic Imaging +12

MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines

Yongsheng Wang, Yinhua Wang, Hongping Xia et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 114 citations · Full text

Erlotinib in the treatment of advanced non-small cell lung cancer: an update for clinicians

Yongsheng Wang, Gerald Schmid‐Bindert, Caicun Zhou · Therapeutic Advances in Medical Oncology · 2011 · 111 citations · Full text

Tumor Biology, Advanced Nsclc, Medicine +12